Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Espildora, E. Acosta, G. Olveira, C. Olveira, E. Casado, A. Dorado (Malaga, Spain). Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis. Eur Respir J 2007; 30: Suppl. 51, 344

Member's Comments

No comment yet.

Related content which might interest you: Supplementation with polyunsaturated fatty acids influence the inflammatory response and airway nitric oxide in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006 Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth Source: Eur Respir J 2015; 46: 1033-1045 Year: 2015 The role of free fatty acids in idiopathic pulmonary fibrosis Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Association between Ω3 and Ω6 fatty acid dietary intakes and serum inflammatory markers in Spanish COPD patients Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010 The effect of dietary fatty acids on inflammation in primary lung mesenchymal cells Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis Source: Eur Respir J 2007; 29: 958-964 Year: 2007 Is the unbalance between arachidonic acid and docosahexaenoic acid a reversible condition in adults With cystic fibrosis? Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Effects of long-term supplementation of branched-chain amino acids on muscle metabolism in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 638s Year: 2006 Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids? Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Nutritional intervention in cystic fibrosis Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=153 Year: 2003 Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007 Aging decreases pulmonary fibrosis reversibility via remodeling fatty acid metabolism of fibroblasts modulated by PRDM16 Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Nasal NO in cystic fibrosis is associated with CFTR genotype, pseudomonas colonization and fatty acids Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Correlation between inflammatory and oxidation markers in adults with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008 The effect of dietary fatty acids on respiratory infection in human lung cells Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Serum lipid concentrations and malnutrition in adult cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 58s Year: 2006